Relumino — Samsung's Clinically-Trialled Low-Vision Assistive Display Technology

Relumino began in 2016 inside Samsung's C-Lab in-house venture program after researchers found that most people with low vision retain some residual vision but struggle with everyday tasks like watching television. Over seven years the project evolved from a Samsung Gear VR app into a standalone wearable ('Relumino Glass'), a smartphone app, and finally a built-in TV picture mode that outlines objects and boosts contrast, colour and sharpness.
Samsung Medical Center in Seoul ran a three-step clinical evaluation of Relumino from April to November 2022 with 67 low-vision participants, rating satisfaction on a 0-10 scale; separately, Samsung distributed 30 Relumino Glass units free of charge to the Community Agency of the Blind in Gyeonggi Province for real-world usability testing. Relumino Mode is now built into Samsung TV lines including the QN80C, QN90C, QN800C and QN900C, and Samsung's TVs have twice earned the UK charity RNIB's 'Tried and Tested' accreditation (first in 2020) plus TÜV Rheinland's Low Vision Care certification.
The clinical trial and certifications are real but small-scale evidence; Samsung has not published data on how many people actually use Relumino Mode day to day once it ships inside a mass-market TV, so demonstrated reach beyond the 67-person trial and 30-unit pilot remains unverified.

Read the full analysis: https://www.gizmochina.com/2023/03/07/samsung-relumino-project-glasses/